Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov-Dec;65(6):500-505.
doi: 10.4103/ijd.IJD_269_19.

Podoplanin as a Predictive Marker for Identification of High-Risk Mycosis Fungoides Patients: An Immunohistochemical Study

Amal A El-Ashmawy  1 , Maha M Shamloula  2 , Nashwa N Elfar  1
Affiliations

Podoplanin as a Predictive Marker for Identification of High-Risk Mycosis Fungoides Patients: An Immunohistochemical Study

Amal A El-Ashmawy et al. Indian J Dermatol. 2020 Nov-Dec.

Abstract

Background: Podoplanin, an important protein, has been implicated in various cellular processes, including lymphangiogenesis. Podoplanin is a mucin-type transmembrane glycoprotein that is accepted as a novel marker of lymphatic endothelial cells.

Objectives: To study the immunohistochemical expression of podoplanin in the different stages of mycosis fungoides (MF) in comparison to control and to correlate their expression with disease severity and progression.

Materials and methods: The study included 50 patients of MF, clinically diagnosed and assessed by World Health Organization/European Organization for Research And Treatment Of Cancer Consensus and 20 normal persons as control. Skin biopsy specimens were taken from all and examined for expression of podoplanin immunohistochemically.

Results: Significant upregulation of podoplanin expression was detected in all studied patients of MF in comparison to control group. Podoplanin expression in malignant lymphocytes and also lymph vessel density showed significant upregulation in the aggressive clinical presentations as well as the highest stages regarding TNMB staging of MF.

Conclusions: Evaluation of podoplanin expression may be taken into consideration in the future as a useful tool to identify high-risk MF patients. Furthermore, it may open new therapeutic options for the clinical management of those patients.

Keywords: Lymphangiogenesis; mycosis fungoides; podoplanin.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Patch stage, classic mycosis fungoides. (b) Patch stage, classic mycosis fungoides. (c) Patch stage, hypopigmented mycosis fungoides. (d) Patch stage, hyperpigmented mycosis fungoides. (e) Patch stage, folliculotropic mycosis fungoides. (f) Plaque stage, classic mycosis fungoides. (g) Tumor stage, classic mycosis fungoides
Figure 2
Figure 2
Patch stage MF showed moderate podoplanin expression in the epidermis (basal cell layer), epidermotropic malignant lymphocytes and in lymph vessels density (IHC, ×200)
Figure 3
Figure 3
Plaque stage MF showed severe podoplanin expression in the epidermis (basal cell layer), moderately expressed in dermal malignant lymphocytes and severe expression of lymph vessels density (IHC, ×200)
Figure 4
Figure 4
Tumor stage MF showed severe podoplanin expression in the dermal malignant lymphocytes (IHC, ×400)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Wigle J, Harvey N, Dermar M, Lagutina I, Grosveld G, Gunn MD, et al. An essential role for Prox1 in the induction of lymphatic endothelial cell phenotype. EMBO J. 2002;21:1505–13. - PMC - PubMed
    1. Rutkowski J, Ihm J, Lee S, Kilarski WW, Greenwood VI, Pasquier MC, et al. VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy. Am J Pathol. 2013;183:1596–607. - PMC - PubMed
    1. Marsee D, Pinkus G, Hornick JL. Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells. Appl Immunohistchem Mol Morphol. 2009;2:102–7. - PubMed
    1. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G, et al. Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell. 2006;9:261–72. - PubMed
    1. Astarita J, Acton S, Turley S. Podoplanin emerging functions in development, the immune system and cancer. Front Immunol. 2012;3:1–11. - PMC - PubMed